BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

890 related articles for article (PubMed ID: 24599081)

  • 21. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
    Liu Y; Miyoshi H; Nakamura M
    Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
    Moritz M; Geszke-Moritz M
    Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silica nanoparticles as promising drug/gene delivery carriers and fluorescent nano-probes: recent advances.
    Liu Y; Lou C; Yang H; Shi M; Miyoshi H
    Curr Cancer Drug Targets; 2011 Feb; 11(2):156-63. PubMed ID: 21158720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanomedical engineering: shaping future nanomedicines.
    Luo D; Carter KA; Lovell JF
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(2):169-88. PubMed ID: 25377691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association.
    Musunuru K; Sheikh F; Gupta RM; Houser SR; Maher KO; Milan DJ; Terzic A; Wu JC;
    Circ Genom Precis Med; 2018 Jan; 11(1):e000043. PubMed ID: 29874173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanochannel systems for personalized therapy and laboratory diagnostics.
    Grattoni A; Fine D; Ziemys A; Gill J; Zabre E; Goodall R; Ferrari M
    Curr Pharm Biotechnol; 2010 Jun; 11(4):343-65. PubMed ID: 20199382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nano-selenium and its nanomedicine applications: a critical review.
    Hosnedlova B; Kepinska M; Skalickova S; Fernandez C; Ruttkay-Nedecky B; Peng Q; Baron M; Melcova M; Opatrilova R; Zidkova J; Bjørklund G; Sochor J; Kizek R
    Int J Nanomedicine; 2018; 13():2107-2128. PubMed ID: 29692609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug Delivery Applications of Nanoparticles in the Spine.
    Venugopal I; Mehta AI; Linninger AA
    Methods Mol Biol; 2020; 2059():121-143. PubMed ID: 31435918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Embryonic and induced pluripotent stem cells: understanding, creating, and exploiting the nano-niche for regenerative medicine.
    Kingham E; Oreffo RO
    ACS Nano; 2013 Mar; 7(3):1867-81. PubMed ID: 23414366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enabling individualized therapy through nanotechnology.
    Sakamoto JH; van de Ven AL; Godin B; Blanco E; Serda RE; Grattoni A; Ziemys A; Bouamrani A; Hu T; Ranganathan SI; De Rosa E; Martinez JO; Smid CA; Buchanan RM; Lee SY; Srinivasan S; Landry M; Meyn A; Tasciotti E; Liu X; Decuzzi P; Ferrari M
    Pharmacol Res; 2010 Aug; 62(2):57-89. PubMed ID: 20045055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unmet needs in developing nanoparticles for precision medicine.
    Schwartz S
    Nanomedicine (Lond); 2017 Feb; 12(4):271-274. PubMed ID: 28093937
    [No Abstract]   [Full Text] [Related]  

  • 33. Theranostic applications of peptide-based nanoformulations for growth factor defective cancers.
    Ghosh A; Maske P; Patel V; Dubey J; Aniket K; Srivastava R
    Int J Biol Macromol; 2024 Mar; 260(Pt 2):129151. PubMed ID: 38181914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Veterinary nanomedicine: Pros and cons.
    Jafary F; Motamedi S; Karimi I
    Vet Med Sci; 2023 Jan; 9(1):494-506. PubMed ID: 36580403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silica-based nanosystems for therapeutic applications in the skin.
    Arriagada F; Nonell S; Morales J
    Nanomedicine (Lond); 2019 Aug; 14(16):2243-2267. PubMed ID: 31411537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of nanotechnology in developing new therapies for diseases of the nervous system.
    Jain KK
    Nanomedicine (Lond); 2006 Jun; 1(1):9-12. PubMed ID: 17716203
    [No Abstract]   [Full Text] [Related]  

  • 37. Systematic review: the applications of nanotechnology in gastroenterology.
    Brakmane G; Winslet M; Seifalian AM
    Aliment Pharmacol Ther; 2012 Aug; 36(3):213-21. PubMed ID: 22686286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurodegenerative disorders management: state-of-art and prospects of nano-biotechnology.
    Kumar R; Aadil KR; Mondal K; Mishra YK; Oupicky D; Ramakrishna S; Kaushik A
    Crit Rev Biotechnol; 2022 Dec; 42(8):1180-1212. PubMed ID: 34823433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanotechnology enables superior medical therapies.
    Foldvari M; Elsabahy M
    Curr Drug Deliv; 2011 May; 8(3):225-6. PubMed ID: 21291383
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.